Steve Schonfeld’s Milestone Scientific MLSS Stock Holding History

Steve Schonfeld’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-33,900	Closed	-$52K	–	2818
2022 Q1	$52K	Buy	+33,900	New	+$49.5K	﹤0.01%	2334

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Steve Schonfeld's MLSS Position: Q2 2022 in Review

Steve Schonfeld sold out of Milestone Scientific (MLSS) in Q2 2022, closing a stake of 33,900 shares — an estimated $52K sold.

Steve Schonfeld first reported a position in MLSS in Q1 2022 and held it in 1 quarter. The position peaked at $52K in Q1 2022. 39 funds tracked by Wall St. Rank hold MLSS as of Q2 2022.

Steve Schonfeld reported no remaining Milestone Scientific position as of Q2 2022 after selling out during the quarter.
Steve Schonfeld sold 33,900 Milestone Scientific shares in Q2 2022, an estimated $52K.
Steve Schonfeld first reported a position in Milestone Scientific in Q1 2022 and held it in 1 quarter.
Steve Schonfeld's Milestone Scientific position peaked at $52K in Q1 2022.
39 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.